Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
From a strategic perspective, copper peptides provide brands with an ingredient story that feels sophisticated and credible
Front Cell Dev Biol (2021) 9:722412
10.1186/s13578-020-00396-1 Summary Keywords triple-negative breast cancer, ferroptosis, Formononetin, mammalian target of rapamycin complex1, sterol regulatory element-binding protein 1 Citation Xie D, Jiang Y, Wang H, Zhu L, Huang S, Liu S, Zhang W and Li T (2024) Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway
While it is not FDA-approved for medical use, it has gained popularity in the performance and recovery world for its reported effects on: Tendon and ligament repair Joint pain relief Gut lining protection Muscle recovery and regeneration To learn more about BPC-157s full range of potential benefits and its classification as a research compound, see What Is BPC-157
